Michael Lynn

Michael Lynn， M.D. is a Parnter of Adams Street Partners， LLC. Mike is responsible for sourcing and screening private equity investments in the medical device and biopharmaceutical sectors. He serves on the Boards of Directors of Luminous Medical， Pivot Medical， PneumRx， Revascular， TriReme and USGI Medical and is a Board Observer at GlobeImmune.

Michael Lynn， M.D. used to work in VantagePoint Venture Partners， Stanford University， Highland General Hospital and The White House. He is a BA of Carleton College， a magna cum laude of Dartmouth Medical School in Pre-Clinical Sciences and MD of UCLA School of Medicine.